UK MHRA sets a July 2026 EO test report rule for sterile imports, requiring UKAS-accredited EO and ECH residue reports. See how UKCA and GB suppliers can prepare now.

Order 818 takes effect, redefining biomed pathways for MSCs, exosomes, and cellular carriers. Learn how this shift impacts registration, UDI/CE labeling, exports, and supply chain compliance.

Biocompatibility ISO 10993 explained clearly: learn which tests apply to your medical device, how to justify endpoints, and how to avoid costly delays in FDA or EU MDR approval.

Medical device classification FDA explained clearly: learn how to determine Class I, II, or III, avoid costly mistakes, and align testing, risk, and submission strategy early.

Medical device regulatory compliance checklist for MDR, FDA, and UDI: uncover audit gaps, strengthen traceability, and speed safer market access with practical review points.